Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,631 | 528 | 100.0% |
| Education | $3.88 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,264 | 116 | $0 (2024) |
| ABBVIE INC. | $774.52 | 43 | $0 (2024) |
| PFIZER INC. | $689.71 | 47 | $0 (2024) |
| Amgen Inc. | $623.40 | 38 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $573.05 | 41 | $0 (2021) |
| Lilly USA, LLC | $572.09 | 39 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $378.57 | 27 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $319.74 | 24 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $277.23 | 18 | $0 (2021) |
| Exact Sciences Corporation | $223.70 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,039 | 61 | Novo Nordisk Inc ($195.25) |
| 2023 | $844.83 | 51 | AbbVie Inc. ($180.18) |
| 2022 | $870.38 | 48 | Novo Nordisk Inc ($345.53) |
| 2021 | $1,059 | 57 | Novo Nordisk Inc ($519.75) |
| 2020 | $919.13 | 63 | Novo Nordisk Inc ($246.44) |
| 2019 | $1,326 | 92 | Amgen Inc. ($193.12) |
| 2018 | $1,064 | 84 | Novo Nordisk Inc ($152.83) |
| 2017 | $1,512 | 73 | Novo Nordisk Inc ($498.69) |
All Payment Transactions
529 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Diabetes | ||||||
| 12/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Diabetes | ||||||
| 12/12/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: VACCINES | ||||||
| 12/10/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: Oncology | ||||||
| 12/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Diabetes | ||||||
| 11/11/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $33.18 | General |
| Category: Oncology | ||||||
| 11/11/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: VACCINES | ||||||
| 11/05/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: Obesity | ||||||
| 10/14/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $32.26 | General |
| Category: Oncology | ||||||
| 10/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: RESPIRATORY | ||||||
| 10/03/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $5.81 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.96 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Diabetes | ||||||
| 09/03/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.31 | General |
| Category: NEUROSCIENCE | ||||||
| 08/18/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: VACCINES | ||||||
| 08/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Obesity | ||||||
| 07/31/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: Diabetes | ||||||
| 07/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: NEUROSCIENCE | ||||||
| 07/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: Diabetes | ||||||
| 07/17/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: NEUROSCIENCE | ||||||
| 06/26/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 606 | 1,156 | $238,535 | $63,699 |
| 2022 | 8 | 569 | 1,018 | $209,135 | $52,632 |
| 2021 | 11 | 589 | 1,081 | $214,925 | $70,158 |
| 2020 | 13 | 742 | 1,047 | $204,480 | $58,928 |
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 226 | 656 | $157,440 | $33,129 | 21.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 18 | 126 | $20,160 | $7,652 | 38.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 100 | 102 | $9,180 | $7,251 | 79.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 15 | 15 | $5,925 | $4,214 | 71.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 102 | 104 | $7,280 | $3,533 | 48.5% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 16 | 19 | $9,975 | $2,084 | 20.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 31 | 31 | $12,245 | $1,506 | 12.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 14 | 15 | $2,400 | $1,064 | 44.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 16 | 20 | $3,600 | $944.40 | 26.2% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 14 | 14 | $5,180 | $912.40 | 17.6% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 11 | 11 | $2,420 | $583.72 | 24.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 15 | 15 | $1,050 | $509.55 | 48.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 28 | 28 | $1,680 | $314.40 | 18.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 219 | 591 | $141,740 | $30,450 | 21.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 112 | 113 | $10,150 | $7,673 | 75.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 14 | 83 | $13,280 | $5,171 | 38.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 113 | 115 | $8,050 | $3,876 | 48.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 58 | 58 | $22,910 | $3,057 | 13.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 24 | 29 | $5,220 | $1,413 | 27.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 13 | 13 | $6,825 | $806.49 | 11.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 16 | 16 | $960.00 | $184.75 | 19.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 225 | 586 | $140,640 | $38,449 | 27.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 12 | 120 | $19,200 | $7,615 | 39.7% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 104 | 104 | $7,400 | $6,787 | 91.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 29 | 29 | $11,455 | $4,393 | 38.4% |
About Dr. Angelo Bellardini, M.D
Dr. Angelo Bellardini, M.D is a Internal Medicine healthcare provider based in West Paterson, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1780680876.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Angelo Bellardini, M.D has received a total of $8,635 in payments from pharmaceutical and medical device companies, with $1,039 received in 2024. These payments were reported across 529 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($8,631).
As a Medicare-enrolled provider, Bellardini has provided services to 2,506 Medicare beneficiaries, totaling 4,302 services with total Medicare billing of $245,417. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location West Paterson, NJ
- Active Since 06/23/2005
- Last Updated 07/27/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1780680876
Products in Payments
- Ozempic (Drug) $721.46
- Rybelsus (Drug) $401.00
- Tresiba (Drug) $375.56
- RYBELSUS (Drug) $368.45
- JARDIANCE (Drug) $363.21
- JANUVIA (Drug) $342.85
- Victoza (Drug) $296.06
- FARXIGA (Drug) $280.89
- ELIQUIS (Drug) $256.76
- Otezla (Drug) $255.77
- XARELTO (Drug) $237.12
- XIFAXAN (Drug) $231.73
- Aimovig (Biological) $229.23
- Cologuard Collection Kit (Device) $223.70
- PREVNAR 20 (Biological) $222.13
- Vascepa (Drug) $214.08
- MOUNJARO (Drug) $207.86
- VRAYLAR (Drug) $189.13
- TRULICITY (Drug) $163.15
- Creon (Drug) $139.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in West Paterson
Joseph Vitale, Md, MD
Internal Medicine — Payments: $10,504
Dr. Yousef Zibdie, Md, MD
Internal Medicine — Payments: $3,555
Dr. Jocelyn Lim, M.d, M.D
Internal Medicine — Payments: $328.61
Dr. Meena Patel, Md, MD
Internal Medicine — Payments: $289.04
Dr. James Record, M.d, M.D
Internal Medicine
Dr. Francis Ferrante, M.d, M.D
Internal Medicine